SKYE
Skye Bioscience·NASDAQ
--
--(--)
--
--(--)
SKYE fundamentals
Skye Bioscience (SKYE) released its earnings on Mar 10, 2026: revenue was 0 (YoY --), met estimates; EPS was -0.36 (YoY -50.00%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.36
-50.00%
Report date
Mar 10, 2026
SKYE Earnings Call Summary for Q4,2025
- Higher Dose Expansion: Initiated 400mg/600mg IV cohorts to confirm PK/safety, with subcutaneous delivery via ENHANZE for Phase IIb.
- Combination Efficacy: 22.3% weight loss at 52 weeks vs. 6.3% for monlunabant, with no neuropsychiatric risk.
- APC Innovation: Unimolecular construct achieves 3-day dosing equivalence to daily combo, preserving orthogonal mechanisms.
- Phase IIb Focus: GLP-1 experienced patients with plateaued weight loss, targeting Q4 2026 data readout.
Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
Skye Bioscience (SKYE) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Skye Bioscience (SKYE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Skye Bioscience (SKYE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Skye Bioscience (SKYE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Skye Bioscience (SKYE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Skye Bioscience (SKYE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Skye Bioscience’s earnings call?What does Skye Bioscience do and what are its main business segments?What is Skye Bioscience's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Skye Bioscience year over year?What factors drove the changes in Skye Bioscience's revenue and profit?What guidance did Skye Bioscience's management provide for the next earnings period?What were the key takeaways from Skye Bioscience's earnings call?What is the market's earnings forecast for Skye Bioscience next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
